The American Diabetes Association’s bold transformational initiative, Pathway to Stop Diabetes, aims to inspire a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management, and cures.
This call for nominations prioritizes translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The Foundation’s ideal applicant will propose innovative research that will be an important step towards improving the lives of people at risk of diabetes or living with the disease and the pathway to this impact is clear.
FUNDING INFORMATION: Up to $1.625M with different funding depending on the type of award, as listed below.
For the Initiator Award:
- Up to 7 years – up to 2 years in Phase 1 and up to 5 years in Phase II
- Phase I: Up to $100,000 per year with up to 10% of direct costs
- Phase II: Up to $325,000 per year with up to 30% of direct costs
For the Accelerator Award:
- Up to 5 years
- Up to $325,000 per year with up to 30% of direct costs
ELIGIBILITY
Applicants must have US work authorization.
For the Initiator Award: applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant.
For the Accelerator Award: applicants should be early-career investigators holding faculty positions and having demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award.
INTERNAL SELECTION PROCESS
The internal selection process depends on whether your grants are managed by BU or Boston Medical Center (BMC). Use the steps below to determine this information:
- Step 1: Open the BUMC Home Institution Finder
- Step 2: Log in to search the database – search using your last name
- Step 3: Follow one process:
- If you see BU or BU-CAMED, follow BU Process below
- If you see BMC, follow the BMC Process below
BU Process
BU may submit up to two nominations: one nomination spanning basic through preclinical research and one nomination spanning clinical through public health research. Please see page one of this information document for information about each category.
Interested applicants should submit the following materials via InfoReady Review by March 17, 2026
- Two-page Research Strategy Summary describing your scientific question(s), the strategies and approaches used to address the question(s), significance, and potential risks and challenges. Reference may be listed on one additional page
- Move the Needle Statement (150 words max) describing how the proposed research has the potential to significantly impact the lives of people at risk for or living with diabetes
- Contact information for three Reference Letter writers, which must be from:
- Initiator Award: a current mentor, graduate or medical training advisor, and a past or current collaborator
- Accelerator Award: department chair, past or current collaborator
- Biosketch in SciENcv format (see guidance on how to prepare that here)
As necessary, a faculty committee drawn from both campuses will review and select the institutional nominees.
BMC Process
BMC may submit up to two nominations: One nomination spanning basic science through preclinical research and one nomination spanning clinical through public health research. Please see page one of this information document for information about each category.
If you are a BUMC faculty member who works in BMC space or you are a fellow whose faculty advisor is a BMC investigator, please contact the Program Manager of Strategic Research Growth, Carolina Giudice carolina.giudice@bmc.org by Friday, February 20 to express interest in this opportunity.
BMC investigators do not submit applications through InfoReady Review for this LSO. BMC investigators should contact Carolina for guidance on next steps.
DEADLINES
BMC – Expression of Interest Due: Friday, February 20, 2026
BU – Internal Materials Due: Tuesday, March 17, 2026 by 11:59 pm EST
Anticipated Notification Date: Friday, April 6, 2026
External Proposal Due: Tuesday, May 19, 2026 by 5 pm ET
In requesting to be considered for this limited submission funding opportunity, you are making a commitment, if selected, to submit your proposal to the sponsor in a timely manner and to Sponsored Programs in accordance with the Proposal Submission Policy
BACK TO TOP↑